{
    "eid": "2-s2.0-85090895346",
    "title": "Towards the elimination of viral hepatitis in Thailand by the year 2030",
    "cover-date": "2020-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Virology",
            "@code": "2406",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Elimination",
        "HAV",
        "HBV",
        "HCV",
        "Thailand",
        "Viral hepatitis"
    ],
    "authors": [
        "Nawarat Posuwan",
        "Nasamon Wanlapakorn",
        "Palittiya Sintusek",
        "Rujipat Wasitthankasem",
        "Kittiyod Poovorawan",
        "Sompong Vongpunsawad",
        "Yong Poovorawan"
    ],
    "citedby-count": 8,
    "ref-count": 53,
    "ref-list": [
        "Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity",
        "Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study",
        "The success of a universal hepatitis B immunization program as part of Thailand's EPI after 22 Years' implementation",
        "Decreasing hepatitis C virus infection in Thailand in the past decade: evidence from the 2014 national survey",
        "Combating hepatitis B and C to reach elimination by 2030",
        "The important role of early diagnosis and preventive management during a large-scale outbreak of hepatitis A in Thailand",
        "Problems and prevention of viral hepatitis in Thailand",
        "Age-specific prevalence of hepatitis A virus antibody in Thailand",
        "Changing seroepidemiology of hepatitis A virus infection in Thailand",
        "Declining trend of hepatitis A seroepidemiology in association with improved public health and economic status of Thailand",
        "Changes in hepatitis A virus (HAV) seroprevalence in medical students in Bangkok, Thailand, from 1981 to 2016",
        "Modeling the long-term persistence of hepatitis A antibody after a two-dose vaccination schedule in Argentinean children",
        "Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine",
        "Cost-benefit analysis of hepatitis A vaccination in Thailand",
        "Seroepidemiology of antibody to hepatitis A in the rural eastern part of Thailand",
        "Declining trend in the seroprevalence of infection with hepatitis A virus in Thailand",
        "SEARCH010/RV254 Study Team. Reply to Chen et al",
        "Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand",
        "Acute, hepatitis-A super-infection in HBV carriers, or chronic liver disease related to HBV or HCV",
        "Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas",
        "Department of communicable diseases surveillance and response",
        "Universal hepatitis B vaccination in taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group",
        "Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers",
        "Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers",
        "Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand",
        "Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region",
        "Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers",
        "Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization",
        "Implementation of hepatitis B vaccine in high-risk young adults with waning immunity",
        "Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand",
        "Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand",
        "Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination",
        "Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen",
        "Impact of hepatitis B immunisation as part of the EPI",
        "Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization",
        "Chronic hepatitis B virus infection in Asian countries",
        "Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis",
        "Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study",
        "Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention",
        "Efficacy of maternal tenofovirdisoproxilfumarate in interrupting mother-to-infant transmission of hepatitis B virus",
        "Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection",
        "Tenofovir to prevent hepatitis B transmission in mothers with high viral load",
        "Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study",
        "Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice",
        "Tenofovir versus placebo to prevent perinatal transmission of hepatitis B",
        "Hepatitis B and hepatitis C virus in Thai blood donors",
        "A report of three cases of AIDS in Thailand",
        "Seroepidemiology and genotypes of hepatitis C virus in Thailand",
        "Estimating the impact of expanding treatment coverage and allocation strategies for chronic hepatitis C in a direct antiviral agent era",
        "Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence",
        "Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: implications for HCV elimination in the new therapeutic era, a population-based study",
        "Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60004391",
            "affilname": "Thailand National Science and Technology Development Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004391",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology",
        "Chulalongkorn University and Hospital",
        "Chulalongkorn University",
        "National Science and Technology Development Agency"
    ]
}